PT  - JOURNAL ARTICLE
AU  - Wei, Deying
AU  - Tan, Yingchun
AU  - Liu, Ming
AU  - Tan, Chunsheng
TI  - Progress in Diagnosis and Treatment of Small Cell Carcinoma of the Cervix
AID  - 10.1007/s11805-007-0367-2
DP  - 2007 Oct 01
TA  - Chinese Journal of Clinical Oncology
PG  - 367--371
VI  - 4
IP  - 5
4099  - http://www.cancerbiomed.org/content/4/5/367.short
4100  - http://www.cancerbiomed.org/content/4/5/367.full
SO  - Cancer Biol Med2007 Oct 01; 4
AB  - Small cell carcinoma of the cervix (SCCC) belongs to the neuroendocrine carcinomas, and it is a rare gynecological tumor of high-potential malignancy. It has a poorer prognosis compared to cervical squamous cancer or adenocarcinoma, and the therapeutic regimen of the disease differs. Diagnosis is based on pathomorphological characteristics, i.e., the small and round cancer cells (oat cell) which are uniform in shape and size, with the immunohistochemical marker helpful for diagnosis. Combined therapy is first recommended. Postoperative chemotherapy with platinum/etoposide (PE), vincristine/adriamycin/cyclophosphamide (VAC) and taxel/carboplatin (TP) can markedly improve the prognosis of early SCCC patients.